This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Retinalyze, LLC Begins Enrolling Ophthalmology Practices

Stocks in this article: HDVY

Retinalize, LLC is pleased to announce that it has signed contracts with several large multi-physician Ophthalmology groups in Florida to begin using the Retinalytics SVM analysis technology to assist physicians in the diagnosis of macular degeneration. Retinalize, LLC is a 50%/50% joint venture between Health Discovery Corporation (OTCBB: HDVY), a molecular diagnostics leader in the use of patent protected advanced mathematical techniques for personalized medicine, and Doctors Optimal Formula LLC , a physician exclusive anti-aging, health and wellness company.

Age-related Macular Degeneration (AMD) is the leading cause of blindness in US adults 55 years and older and is a progressive eye disease affecting more than 15 million Americans, with over 200,000 new cases diagnosed each year.

These new ophthalmology physician contracts are in addition to the recently signed exclusive agreement with the 5500 member National EYEPA Coalition which is exclusive to optometrists.

“It’s incredibly exciting to see the positive responses we have seen since recently launching the Retinalytics SVM analysis technology,” states Howard Loff, M.D., CEO of Retinalyze, LLC. “In addition to having signed up the National EYEPA Coalition, we have now been fortunate to also sign up some of the largest Ophthalmology practices in Florida. We expect this trend to continue throughout the United States as well as internationally. As a result of the positive feedback that we are receiving from both optometrists and ophthalmologists alike, we hope Retinalytics SVM analysis technology will become the new standard of care in assisting doctors in their examination of ophthalmic diseases.”

Stephen D. Barnhill, M.D., Chairman and CEO of Health Discovery Corporation, added, “We are extremely pleased to see the rapid growth in the number of both optometrists and ophthalmologists signing up to use the Retinalytics SVM analysis technology for macular degeneration. I expect as the additional modules for diabetic retinopathy, hypertensive retinopathy and glaucoma are released, the revenue generated by our current and future optometry and ophthalmology customers will be significantly increased.”

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,672.60 -141.38 -0.79%
S&P 500 2,051.82 -11.33 -0.55%
NASDAQ 4,757.8790 +7.4820 0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs